2025 Challenges for Medical Device Manufacturers and Researchers

In this episode, we explore how the 2025 tariff policies are creating ripple effects across the healthcare supply chain, with a focus on medical device manufacturers, clinical researchers, and pharmaceutical logistics. As new trade barriers disrupt the flow of critical components, materials, and technologies, healthcare firms are battling increased costs, regulatory hurdles, and delays in product delivery.We dive into how tariffs on imports from key regions like China and Europe are affecting R&D timelines, device approval processes, and cross-border collaboration. Discover how companies are adapting through local sourcing, strategic partnerships, and the use of market intelligence to navigate uncertain global supply routes and regulatory frameworks.